- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02460718
ENCOURAGE: Evaluating Community Peer Advisors and Diabetes Outcomes in Rural Alabama (ENCOURAGE)
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The purpose of this project was to provide robust evidence on the effectiveness of a peer support intervention in improving diabetes outcomes by conducting a group-randomized, controlled implementation trial of a volunteer peer support intervention.
The study had three specific aims:
Aim 1. In Phase I (months 0-8), to perform a qualitative needs assessment with peer advisors and health care providers to inform peer advisor roles and responsibilities (i.e., the intervention) and peer advisor recruitment strategies, curriculum and training; and patient recruitment plans.
Aim 2. Also in Phase I, to pilot our collaboratively developed intervention and, based on pilot test results, to recruit and train peer advisors for the intervention, and begin patient recruitment.
Aim 3. In Phase II (months 9-32), conduct the group randomized implementation trial and evaluate it using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- 19 or older in age, diagnosed with diabetes, under the care of a doctor
Exclusion Criteria:
- not community dwelling, less than 19 years old, pregnant, end-stage medical conditions with limited life expectancy, no access to telephone, does not speak english
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: control group
Participants received 1-hour group diabetes education class covering diabetes basics, healthy eating, stress reduction, physical activity, social support, and how to get the most out of their doctors visit.
Participants also received a diabetes report card showing their Hba1c, blood pressure, ldl cholesterol, and body weight.
|
|
|
Expérimental: Encourage study
Participants in the intervention arm were paired with a peer coach, interacting by telephone weekly for the first 8 weeks and then monthly for a total of 10 months. Participants also received 1-hour group diabetes education class covering diabetes basics, healthy eating, stress reduction, physical activity, social support, and how to get the most out of their doctors visit. Participants also received a diabetes report card showing their Hba1c, blood pressure, ldl cholesterol, and body weight. |
This intervention tested the effects of a peer coaching program plus brief diabetes education versus brief diabetes education alone on diabetes outcomes.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Glycated hemoglobin (A1c)
Délai: Change in A1c in 12 months
|
fingerstick, point-of-care a1c test
|
Change in A1c in 12 months
|
|
Blood pressure
Délai: Change in blood pressure measure in 12 months
|
Measured using digital automated blood pressure monitor
|
Change in blood pressure measure in 12 months
|
|
LDL cholesterol
Délai: Change in LDL cholesterol in 12 month
|
measured using finger stick, spectrophotometer to measure LDL cholesterol
|
Change in LDL cholesterol in 12 month
|
|
diabetes self-care behaviors questionnaire
Délai: Change in diabetes self-care behaviors at 12 months
|
aspects of diabetes self-management such as taking medications as directed, self-report of exercise, and eating behaviors
|
Change in diabetes self-care behaviors at 12 months
|
|
depressive symptoms
Délai: change in depressive symptoms at 12 months
|
self-report using Patient Health Questionnaire 8 (PHQ8)
|
change in depressive symptoms at 12 months
|
|
quality of life
Délai: Change in quality of life measures at 12 months
|
self-report using Short form-1 (SF1), and Euroquol (EQ-5D)
|
Change in quality of life measures at 12 months
|
|
patient activation
Délai: change in patient activation in 12 months
|
self-report using the 13 item Patient Activation Measure (PAM13)
|
change in patient activation in 12 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
body mass index
Délai: change in BMI in 12 months
|
weight measured using digital scale, height measured using stadiometer
|
change in BMI in 12 months
|
|
diabetes knowledge
Délai: change in diabetes knowledge in 12 months
|
assessed using the Spoken Knowledge in Low Literacy in Diabetes Scale
|
change in diabetes knowledge in 12 months
|
|
trust in physicians
Délai: change in trust in physicians in 12 months
|
assessed using the Trust in Physicians Scale
|
change in trust in physicians in 12 months
|
|
composite measure of healthcare utilization
Délai: Change in health care utilization in 12 months
|
self-report by participant, number of times utilized healthcare services
|
Change in health care utilization in 12 months
|
Collaborateurs et enquêteurs
Collaborateurs
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- T0808270039
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur ENCOURAGE Study
-
Apple Inc.Stanford UniversityComplétéFibrillation auriculaire | Arythmies cardiaques | Flutter auriculaireÉtats-Unis
-
Radicle ScienceComplétéLa dépression | La douleur | Dormir | AnxiétéÉtats-Unis
-
Radboud University Medical CenterUCB Pharma; Verily Life Sciences LLCActif, ne recrute pasMaladies du cerveau | Maladies du système nerveux central | Maladies du système nerveux | Maladie de Parkinson | Troubles parkinsoniens | Maladies des noyaux gris centraux | Troubles du mouvement | Maladies neurodégénérativesPays-Bas
-
Radboud University Medical CenterUCB Pharma; Verily Life Sciences LLCComplétéMaladies du cerveau | Troubles du mouvement | Maladies neurodégénératives | Paralysie supranucléaire progressivePays-Bas
-
Radicle ScienceComplété
-
Radicle ScienceComplété
-
Radicle ScienceComplété
-
Digisight Technologies, Inc.InconnueLa rétinopathie diabétique | Dégénérescence maculaire liée à l'âge | MétamorphopsieÉtats-Unis
-
Radicle ScienceComplétéFonction sexuelle | Satisfaction sexuelleÉtats-Unis
-
St. Joseph's Healthcare HamiltonSuspendu